Feeling stuck, disconnected, or flat
Emotional overwhelm
Chronic stress or burnout
Fatigue from medications that haven’t worked
Brain fog, focus issues, or sleep problems
Request a free phone consultation via call, form, or online booking.
Meet with a provider, review your history, get a personalized plan, and we'll submit for insurance approval.
First session includes device “mapping” and your initial treatment.
Sessions last 3–20 minutes; relax during treatment and continue your day as usual afterward.
FDA Approved
For adults struggling with
treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions.
Sustainable Relief
About 70% of patients show a clinically meaningful response, with treatments easily integrated into your life.
Covered by Insurance
Nasal esketamine is covered by several major insurance payers, making it an accessible option for many if you've tried antidepressants and therapy.
TMS therapy has been FDA cleared since 2008, proven to be safe & effective, and covered by most major insurance providers.
While you may feel a slight tapping sensation, most patients adapt to it after just a couple of sessions.
Many patients start to see an improvement after just 3-4 weeks of treatment.
Safe & Effective
About 79% of patients who complete a full course of TMS show a clinically meaningful response and about 53% experience a remission, meaning their symptoms go away completely.
Fits In Your Schedule
Sessions are 3-20 minutes and you can drive to and from your appointments. The full course covered by insurance usually takes about 6-8 weeks to complete.
Covered By Insurance
All major payers cover TMS therapy for treatment-resistant depression. If you've tried multiple antidepressants and therapy, there's a good chance your insurance covers it.
Esketamine is a prescription nasal spray that is fast-acting, FDA approved, and covered by most major insurance providers, and is used to treat adults with treatment-resistant depression (TRD), or major depressive disorder with suicidal ideation.
Unlike oral antidepressants, it is a novel mechanism that acts on different receptors (NMDA vs. serotonin receptors) to treat depression and bring fast relief.
Induction: Twice weekly for the first 4 weeks.
Optimization: Once a week for the following four weeks.
Maintenance: Weekly or bi-weekly treatments as needed. At 8 weeks, you will meet with your provider to discuss the best treatment cadence going forward.
- Does not need to be taken with an oral antidepressant
- Following administration, you will be observed for 2 hours by your provider
- Patients cannot drive from their appointment due to some side effects, so please find a ride on treatment days. Your provider will discuss the side effect profile further at your evaluation.
TMS Patient
"I always look forward to my appointments with SVB. They are always educational and helpful to my mental health and I am always learning something new to help me with my diagnoses. I always refer my friends and family to SVB. Shoutout to Dr. Ng!!"
Patient
"The staff at Sun Valley are professional. They are always on top of scheduling/reminding me of upcoming appointments. Nika Varin is awesome, she has helped me a lot in the short time I've known her. If you are having second thoughts on whether you should go to SV...just do it, you won't regret it."
TMS Patient
"Dr. Ng and my psychologist Eric are the best. I'm so glad I was referred to them. They helped turn my life around and I am in a much better place because of them. Thank you!"
Dr. Ng is a Mexicali native who started his private practice in Imperial County in 1994. He became a Medical Doctor at the University of Nuevo Leon in 1987. After completing his year of social service in the city of Monterrey in 1988, he entered specialized training in Psychiatry, in El Paso Texas in 1989 and continued in San Diego California in 1992. Dr. Ng is currently the principal investigator for Sun Valley Research Center, Inc.
He completed a year of subspecialty training in Psychosomatic Medicine right before moving to Imperial County, California. He is certified by the American Board of Psychiatry and Neurology in General Psychiatry and in Psychosomatic Medicine, as well as by the Mexican Board of Psychiatry. He is also a distinguished fellow of the American Psychiatric Association.
He has served as chairman and member of the Physician Wellbeing and Bioethic committees at both local hospitals ECRMC and PMH. He is a consultant at various organizations and clinics. He is a member of the American Psychiatric Association, the Imperial County Medical Society, the San Diego Psychiatric Society and the American Medical Association.